Utilizing Subject Matter Experts to Support Research in the Biobank Field
PLEASE REFER TO ATTACHED REVISED SCOPE
Background
Research in biobanking has the potential to revolutionize healthcare by providing researchers with access to large-scale, high-quality biological samples and associated data. Developing a comprehensive biobank strategy and identifying research priorities based on the utilization of biobank samples and services will help advance medical research, improve health treatments, and promote precision medicine outcomes.
By developing a comprehensive biobank strategy and research framework, DoH can harness the power of biobanking to drive innovation, improve patient outcomes, and advance the field of precision medicine. A well-designed biobank strategy will enable the health life-science ecosystem to:
1. Identify genetic and environmental factors influencing disease susceptibility and treatment response
2. Discover biomarkers for early disease detection, prognosis, and treatment monitoring
3. Leverage biobank data to stratify patient populations for clinical trials, identify potential drug targets, and understand drug efficacy and safety profiles
4. Investigate the impact of lifestyle, socio-economic, and environmental factors on health outcomes across diverse populations
5. Study the genetic basis of complex diseases and traits through genome-wide association studies (GWAS) and polygenic risk scoring
6. Facilitate research on rare genetic disorders by building rare disease registries within biobanks
7. Address ethical, legal, and social implications (ELSI) surrounding biobank research, including informed consent, data privacy, and equitable access to benefits
Objective
Developing a comprehensive biobank strategy and identifying research priorities based on the utilization of biobank samples and services to help medical researchers elevate research outcomes, improve health treatments, and advance precision medicine. Key areas of focus include:
1. Precision Medicine: Utilizing biobank data to understand genetic and environmental factors influencing disease susceptibility and treatment response.
2. Biomarker Discovery: Identifying biomarkers for early disease detection, prognosis, and treatment monitoring using comprehensive biobank datasets.
3. Drug Development: Leveraging biobank data to stratify patient populations for clinical trials, identify potential drug targets, and understand drug efficacy and safety profiles.
4. Population Health Studies: Investigating the impact of lifestyle, socio-economic, and environmental factors on health outcomes across diverse populations using large-scale biobank cohorts.
5. Genomic Epidemiology: Studying the genetic basis of complex diseases and traits, such as cardiovascular disease, diabetes, cancer, and neurological disorders, through genome-wide association studies (GWAS) and polygenic risk scoring.
6. Rare Diseases Research: Building rare disease registries within biobanks to facilitate research on rare genetic disorders, including diagnosis, natural history, and therapeutic interventions.
7. Ethical and Legal Considerations: Addressing ethical, legal, and social implications (ELSI) surrounding biobank research, including informed consent, data privacy, and equitable access to benefits.